UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
Alphatec Holdings
ATEC
$1.14B
| $17.5M | ﹤0.01% |
2,018,823
+74,138
| +4% | +$675K |
2018 Q2
32 quarters
|
|
2827
Tema Space Innovators ETF
NASA
$4.07B
| $17.5M | ﹤0.01% |
+574,661
| New | +$18.4M |
2026 Q2
0 quarters
|
|
2828
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.3B
| $17.4M | ﹤0.01% |
119,152
-7,475
| -6% | -$1.04M |
2014 Q4
46 quarters
|
|
2829
Rush Street Interactive
RSI
$1.41B
| $17.4M | ﹤0.01% |
585,525
+52,425
| +10% | +$1.38M |
2020 Q3
23 quarters
|
|
2830
Community Bank
CBU
$3.39B
| $17.4M | ﹤0.01% |
259,422
+107,266
| +70% | +$6.78M |
2014 Q4
46 quarters
|
|
2831
ENI
E
$79B
| $17.4M | ﹤0.01% |
371,463
+90,924
| +32% | +$4.87M |
2014 Q4
46 quarters
|
|
2832
Teladoc Health
TDOC
$1.6B
| $17.4M | ﹤0.01% |
2,052,026
+325,203
| +19% | +$2.16M |
2015 Q3
43 quarters
|
|
2833
Peabody Energy
BTU
$1.95B
| $17.4M | ﹤0.01% |
752,615
-171,864
| -19% | -$4.57M |
2017 Q2
36 quarters
|
|
2834
Cracker Barrel
CBRL
$1.45B
| $17.4M | ﹤0.01% |
326,380
-40,422
| -11% | -$1.4M |
2014 Q4
46 quarters
|
|
2835
CALL
NetEase
NTES
$82.9B
| $17.4M | ﹤0.01% |
135,700
+60,200
| +80% | +$7.11M |
2023 Q1
13 quarters
|
|
2836
CALL
Cleveland-Cliffs
CLF
$6.54B
| $17.4M | ﹤0.01% |
1,850,600
+1,520,200
| +460% | +$16.7M |
2023 Q2
12 quarters
|
|
2837
GraniteShares 2x Long MRVL Daily ETF
MVLL
$106M
| $17.4M | ﹤0.01% |
+302,570
| New | +$10M |
2026 Q2
0 quarters
|
|
2838
Enliven Therapeutics
ELVN
$3.62B
| $17.4M | ﹤0.01% |
342,115
+58,571
| +21% | +$2.49M |
2024 Q1
9 quarters
|
|
2839
Avantis International Small Cap Value ETF
AVDV
$19.2B
| $17.3M | ﹤0.01% |
168,225
+32,657
| +24% | +$3.48M |
2022 Q3
15 quarters
|
|
2840
Tandem Diabetes Care
TNDM
$1.18B
| $17.3M | ﹤0.01% |
1,146,580
-901,221
| -44% | -$15.7M |
2014 Q4
46 quarters
|
|
2841
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$146B
| $17.3M | ﹤0.01% |
733,542
+98,275
| +15% | +$2.18M |
2014 Q4
46 quarters
|
|
2842
PUT
Roku
ROKU
$23.9B
| $17.3M | ﹤0.01% |
125,000
-321,900
| -72% | -$39.3M |
2019 Q4
26 quarters
|
|
2843
Ubiquiti
UI
$35.9B
| $17.2M | ﹤0.01% |
32,298
+16,218
| +101% | +$12.2M |
2014 Q4
46 quarters
|
|
2844
CALL
Interactive Brokers
IBKR
$34.4B
| $17.2M | ﹤0.01% |
197,426
-48,494
| -20% | -$4.04M |
2024 Q4
6 quarters
|
|
2845
CALL
Moderna
MRNA
$101B
| $17.2M | ﹤0.01% |
245,226
-2,846,600
| -92% | -$147M |
2020 Q3
23 quarters
|
|
2846
Patrick Industries
PATK
$2.53B
| $17.2M | ﹤0.01% |
191,157
+11,514
| +6% | +$1.1M |
2014 Q4
46 quarters
|
|
2847
PUT
On Holding
ONON
$12.5B
| $17.1M | ﹤0.01% |
483,100
+202,600
| +72% | +$7.41M |
2024 Q4
6 quarters
|
|
2848
Digi International
DGII
$2.4B
| $17.1M | ﹤0.01% |
228,083
+93,113
| +69% | +$5.77M |
2014 Q4
46 quarters
|
|
2849
Ingevity
NGVT
$2.07B
| $17.1M | ﹤0.01% |
228,765
+81,093
| +55% | +$5.84M |
2016 Q2
40 quarters
|
|
2850
GRAIL Inc
GRAL
$5.42B
| $17.1M | ﹤0.01% |
249,796
+64,403
| +35% | +$3.79M |
2024 Q2
8 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.